The Biotechnology Innovation Organization (BIO) is committed to creating a more globally competitive biotechnology industry by promoting and enhancing workforce development, diversity, and inclusion (WDDI). Our published principles inform our WDDI initiatives including the development of resources to foster an inclusive biotech industry.
BIO’s board-level WDDI Committee is chaired by Helen Torley, President & CEO of Halozyme.
Learn who serves on BIO's WDDI committee.
Below is a list of resources available.
